MergerLoop
  • Home
  • All deals
  • Newsletter
  • 20 weeks in report
Register

MergerLoop is a DDLoop project

Register

Pemba / Accelagen

Approved · Waiver · decided in 20 days, 19 Nov 2026

Financial Services & InsuranceWA-45043ACCC register

Pemba Capital Partners, through Curis BidCo Pty Ltd, proposes to acquire 100% of the shares in Accelagen Pty Ltd. Accelagen is an Australian contract research organisation providing clinical development and regulatory affairs services to biotechnology, pharmaceutical, and medical device companies. This is a share acquisition by the private equity fund manager.

Timeline

  1. 30 Oct 2026Filed with the ACCC
  2. 19 Nov 2026Notification waiver determination publishedPDF · 143.2 KB

Acquisition details

Curis BidCo Pty Ltd (BidCo) proposes to acquire 100% of the issued shares in Accelagen Pty Ltd (Accelagen) from Accelagen’s existing founding shareholders (the Acquisition). BidCo is a special purpose vehicle and is an indirect wholly owned subsidiary of Curis HoldCo Pty Ltd (HoldCo). HoldCo is currently wholly owned by Pemba Capital Fund IV, L.P., a private equity fund managed by Pemba Capital Partners Pty Ltd (Pemba), based in Sydney. The Acquisition will be implemented by way of a Share Purchase Deed. Following completion, BidCo will exercise control of Accelagen. Pemba is an investor in high-growth and entrepreneurial businesses, with over AUD 2 billion in assets under management. Pemba has interests across various sectors, including business services, education & training, financial services, healthcare, and technology. Accelagen is an Australian-based, full-service contract research organisation (CRO), with a focus on clinical development and regulatory affairs, providing guidance and support throughout all stages of product development to biotechnology, pharmaceutical and medical device companies, including the development, initiation and management of Phase I-IV clinical trials.

Parties

Acquirer
Curis BidCo Pty Ltd ACN 703 731 140
Target
Accelagen Pty Ltd ABN 11 142 888 766
Other parties
Curis HoldCo Pty Ltd ACN 703 729 864, PEMBA CAPITAL PARTNERS PTY LIMITED ABN 24 121 906 045, Pemba Capital Fund IV, L.P.
ANZSIC
  • 6240 Financial Asset Investing
  • 6910 Scientific Research Services

More Financial Services & Insurance deals

  • Pemba / Bio101Waiver · Approved
  • Pemba / SuperGuardianWaiver · Approved
  • Pemba / Hewison Private WealthWaiver · Approved
  • Steadfast / Axiom Insurance BrokersNotification · Under assessment
  • Amwins / Dragoneer / KKR / Temasek Consortium – SteadfastNotification · Under assessment
  • Vista Equity Partners / Enterprise Trust Business of HID Global CorporationWaiver · Approved